Position in RLAY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$80,359
+$41,734 QoQ
Shares Held
4,295
+10.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#202
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. RLAY ranks #65 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
|
36,758 | $2,000,002 |
All Filings in RLAY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,359 | 4,295 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $38,625 | 3,882 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $17,546 | 2,074 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $10,826 | 2,074 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $6,971 | 2,015 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $12,534 | 4,784 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,738 | 1,150 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $16,595 | 2,344 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $18,145 | 2,783 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,511 | 905 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $9,468 | 860 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $25,759 | 3,063 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $38,270 | 3,047 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $38,951 | 2,365 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $34,959 | 2,340 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $52,748 | 2,358 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $50,970 | 3,043 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $77,997 | 2,606 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $79,416 | 2,586 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $35,597 | 1,129 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $150,714 | 4,119 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $161,061 | 4,659 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $193,628 | 4,659 | Shares | Sole | 2021-01-25 | |
| No filing history on record for this holder in this stock. | ||||||